Results 1 to 10 of about 32,346 (218)

The Effects of Allopurinol on Levels of Cardiac Troponin Following Non-ST Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial [PDF]

Pharmaceutical Sciences, 2021
Background: Given the potential anti-ischemic effects of allopurinol, we aimed to assess whether allopurinol administration may reduce myocardial injury following non-ST elevation myocardial infarction (NSTEMI). Methods: A randomized clinical trial (RCT)
Sajad Khiali, Parvin Sarbakhsh, Sina Mashayekhi, Elham Mohamadrezapour, Samaneh Dousti, Taher Entezari-Maleki   +5 more
doaj   +1 more source

Oxidants and antioxidants in myocardial infarction (MI): Investigation of ischemia modified albumin, malondialdehyde, superoxide dismutase and catalase in individuals diagnosed with ST elevated myocardial infarction (STEMI) and non-STEMI (NSTEMI) [PDF]

Journal of Medical Biochemistry, 2021
Background: Coronary ischemia can lead to myocardial damage and necrosis. The pathogenesis of cardiovascular diseases often includes increased oxidative stress and decreased antioxidant defense.
Aladağ Nesim, Asoğlu Ramazan, Ozdemir Mahmut, Asoğlu Emin, Derin Atabey Rukiye, Demir Canan, Demir Halit   +6 more
doaj   +1 more source

Acute myocardial infarction at a district hospital in KwaZulu-Natal – Management and outcomes

South African Family Practice, 2022
Background: Acute myocardial infarction (AMI) following ischaemic heart disease (IHD) is associated with increased morbidity and mortality. The condition remains a management challenge in resource-constrained environments.
Zakariya Badat, Selvandran Rangiah
doaj   +1 more source

Management of Acute Coronary Syndrome in the COVID Era

Methodist DeBakey Cardiovascular Journal, 2021
Management of acute coronary syndrome (ACS) has emerged as a challenge during the COVID-19 era. There has been a significant increase in the morbidity and mortality associated with ACS both as a direct and an indirect consequence of the pandemic. In this
Ronak Bahuva, Joe Aoun, Sachin S. Goel
doaj   +1 more source

Differences in mortality and causes of death between STEMI and NSTEMI in the early and late phases after acute myocardial infarction

PLoS ONE, 2021
Background The detailed causes of death in non–ST-segment–elevation myocardial infarction (NSTEMI) have not been adequately evaluated compared to those in ST-segment elevation myocardial infarction (STEMI).
Yasuaki Takeji, Hiroki Shiomi, Takeshi Morimoto, Ko Yamamoto, Yukiko Matsumura-Nakano, Kazuya Nagao, Ryoji Taniguchi, Kyohei Yamaji, Tomohisa Tada, Eri Toda Kato, Yusuke Yoshikawa, Yuki Obayashi, Satoru Suwa, Moriaki Inoko, Natsuhiko Ehara, Toshihiro Tamura, Tomoya Onodera, Hiroki Watanabe, Mamoru Toyofuku, Kenji Nakatsuma, Hiroki Sakamoto, Kenji Ando, Yutaka Furukawa, Yukihito Sato, Yoshihisa Nakagawa, Kazushige Kadota, Takeshi Kimura, the CREDO-Kyoto AMI Registry Wave-2 Investigators   +27 more
doaj   +2 more sources

Vascular senescence and atherosclerotic plaque vulnerability: investigating the telomere-mitochondria crosstalk—rationale and design of the VICTORIA Study [PDF]

Exploration of Cardiology
Vascular aging is recognized as one of the hallmarks of atherosclerosis. Currently, a growing body of evidence suggests that there exists a mutual crosstalk between telomere dysfunction and mitochondrial dysmetabolism during the process of vascular ...
Jonica Campolo, Paola Canale, Emanuela Piccaluga, Irene Bossi, Gianluca Gazzaniga, Marina Parolini, Cinzia Dellanoce, Giuseppe Esposito, Jacopo Oreglia, Rudina Ndreu, Andrea Borghini, Maria Grazia Andreassi   +11 more
doaj   +1 more source

High medium-term incidence of major cardiovascular events in discharged patients with unstable angina

International Journal of Cardiology: Heart & Vasculature, 2023
The introduction of high-sensitivity troponin (hsTn) assays has reduced the diagnosis of unstable angina (UA) in favor of non-ST elevation myocardial infarction (NSTEMI) in the context of non-ST elevation acute coronary syndrome (NSTEACS).
Marta Herrero-Brocal, Francisco Marín, Laura Valverde, Ana M. García-Barrios, Laura Fuertes, Cristina Cambra, Fernando Torres-Mezcua, Ignacio Hortelano, Beatriz Villamia, María Asunción Esteve-Pastor, Esteban Orenes-Piñero, Juan Gabriel Martínez Martínez, José Miguel Rivera-Caravaca, Juan M. Ruiz-Nodar   +13 more
doaj   +1 more source

Are there sex differences in the effect of type 2 diabetes in the incidence and outcomes of myocardial infarction? A matched-pair analysis using hospital discharge data

Cardiovascular Diabetology, 2021
Background To analyze incidence, use of therapeutic procedures, and in-hospital outcomes in patients with ST elevation myocardial infarction (STEMI) and non-ST elevation myocardial infarction (NSTEMI) according to the presence of type 2 diabetes (T2DM ...
Ana Lopez-de-Andres, Rodrigo Jimenez-Garcia, Valentin Hernández-Barrera, Jose M. de Miguel-Yanes, Romana Albaladejo-Vicente, Rosa Villanueva-Orbaiz, David Carabantes-Alarcon, Jose J. Zamorano-Leon, Marta Lopez-Herranz, Javier de Miguel-Diez   +9 more
doaj   +1 more source

Non-ST-segment Elevation Myocardial Infarction Associated with Multiple Comorbidities in a Patient with a Ventriculoperitoneal Shunt for Obstructive Hydrocephalus Following Traumatic Brain Injury

Journal of Cardiovascular Emergencies, 2016
Non-ST elevation myocardial infarction (NSTEMI) has the highest long-term mortality rates of all acute coronary syndromes. Usually, NSTEMI occurs in elderly patients (>75 years of age) with multiple associated diseases.
Marton-Popovici Monica
doaj   +1 more source

PARTICULARITĂȚILE HEMOSTAZIEI ÎN UNELE COMORBIDITĂȚI LA PACIENȚII CU INFARCT MIOCARDIC FĂRĂ SUPRADENIVELAREA SEGMENTULUI ST

Buletinul Academiei de Ştiinţe a Moldovei: Ştiinţe Medicale, 2023
Formarea unui tromb obstructiv în cadrul unei artere rămâne o cauză majoră a mortalității și morbidității la nivel mondial. [1] În ciuda inhibiției eficiente a funcției plachetare de către terapii antiplachetare moderne, acești agenți nu reușesc să ...
Tatiana DANILĂ, Lucia CIOBANU, Mihaela MUNTEANU   +2 more
doaj   +1 more source